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Summary
Intracellular pathogens have evolvedmechanisms to
ensure their survival and development inside their
host cells. Here, we show that glucose is a pivotal
modulator of hepatic infection by the rodent malaria
parasite Plasmodium berghei and that glucose
uptake via the GLUT1 transporter is specifically
enhanced in P. berghei-infected cells. We further
show that ATP levels of cells containing developing
parasites are decreased, which is known to enhance
membrane GLUT1 activity. In addition, GLUT1 mole-
cules are translocated to the membrane of the
hepatic cell, increasing glucose uptake at later
stages of infection. Chemical inhibition of GLUT1
activity leads to a decrease in glucose uptake and
the consequent impairment of hepatic infection, both
in vitro and in vivo. Our results reveal that changes in
GLUT1 conformation and cellular localization seem
to be part of an adaptive host response to maintain
adequate cellular nutrition and energy levels,
ensuring host cell survival and supportingP. berghei
hepatic development.
Introduction
Glucose is the primary source of energy and a key substrate
for most cells. Glucose and other carbohydrates are
transported into cells by members of a family of integral
membrane glucose transporter (GLUT) molecules. To date,
14 members of this family, also called the solute carrier 2A
proteins, have been identified in humans, which are divided
on the basis of transport characteristics and sequence
similarities into several families (Classes I to III) [reviewed
in (Karim et al., 2012; Mueckler and Thorens, 2013)]. GLUT1
is a class I facilitative glucose transporter expressed in liver
cells (Tal et al., 1990) and overexpressed in various tumours
(Smith, 1999). GLUT1 expression is highest in the human
erythrocyte membrane, and has been shown to play a criti-
cal role in cerebral glucose uptake (Koranyi et al., 1991).
GLUT1 is also a receptor for the human T cell leukaemia
virus (Manel et al., 2003), and GLUT1-mediated glucose
transport in T-cells has been shown to regulate Human
immunodeficiency virus infection (Loisel-Meyer et al., 2012).
Mammalian infection by the malaria parasite is initiated
when Plasmodium sporozoites, injected through the bite of
an infected mosquito, cross the endothelium of the liver
sinusoids and enter the liver. Sporozoites then traverse a
few hepatocytes before productively invading a final one,
inside which they asymptomatically differentiate into
exoerythrocytic forms (EEFs) that originate thousands of
red blood cell-infective merozoites (Prudencio et al., 2006).
Merozoites are eventually released to the bloodstream,
initiating the blood stage of infection, and giving rise to
malaria symptoms. The liver stage of a mammalian infection
by Plasmodium is an obligatory uni-directional step in the
parasite’s progression towards the symptomatic, erythro-
cytic phase of its life cycle.
Blood stages ofmalarial parasites are dependent on glycol-
ysis, employed as their main energy source of Adenosine tri-
phosphate (ATP) production (Pfaller et al., 1982; Vander Jagt
et al., 1990; Kirk et al., 1996), a process that has recently
been modelled for the human malaria parasite P. falciparum
(Penkler et al., 2015). Glucose has been shown to be
transported from human blood plasma into the erythrocyte cy-
tosol by GLUT1 (Hellwig and Joost, 1991), and then taken up
by the parasite via a parasite-encoded facilitative hexose
transporter (PfHT) (Woodrow et al., 2000; Joet et al., 2003),
which limits the rate of glucose entry into the parasite’s
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glycolytic pathways (Tjhin et al., 2013). These findings sup-
port novel chemotherapeutic interventions that target PfHT
(Feistel et al., 2008; Slavic et al., 2011b). Studies in the rodent
malaria model, P. berghei, further found that the orthologous
hexose transporter (PbHT) is expressed not only throughout
the parasite’s development within the mosquito vector, but
also during liver and transmission stages ofP. berghei (Slavic
et al., 2010; Slavic et al., 2011a). During their extensive he-
patic replication, developing Plasmodium parasites require
the availability of large amounts of nutrients and energy.
The availability of appropriate amounts of glucose in infected
hepatic cells is thus expected to play an essential role in the
development of liver stage Plasmodium parasites. Inhibition
of PbHT by compound 3361, a specific inhibitor of plasmodial
HTs, impairs hepatic P. berghei development (Slavic et al.,
2011a), supporting the essentiality of glucose uptake forPlas-
modium liver stages. Accordingly, a recent study established
glucose concentration in the culture medium as a key factor
for liver stage parasite development (Itani et al., 2014).
In this study, we employed rodent P. berghei parasites, a
well-established model of malaria infection (Prudencio et al.,
2011), to elucidate the uptake and utilisation of glucose by
Plasmodium liver stages. We investigated the glucose re-
quirements during the course ofP. berghei development in he-
patic cells as well as the host molecular receptors involved in
glucose uptake by those cells. We demonstrate that P.
berghei infection leads to intracellular ATP depletion and en-
hances the translocation of GLUT1 to the cell membrane of in-
fected hepatoma cells, allowing the uptake of significantly
higher amounts of glucose compared with non-infected cells.
We further show that glucose plays an essential role during
the liver stage of infection by the malaria parasite, modulating
its liver stage development both in vitro and in vivo.
Results
Effect of glucose on P. berghei hepatic infection
In order to evaluate glucose requirements throughout the liver
stage of infection, Huh7 cells, a human hepatoma cell line,
were infected with luciferase-expressing P. berghei sporozo-
ites in the presence of varying concentrations of glucose. Glu-
cose concentrations ranged from 1.25 to 20mM, which
includes and expands the physiological range of glucose con-
centrations, 2.5 to 10mM (Shrayyef and Gerich, 2010). Lumi-
nescence intensity, a correlate of parasite load (Ploemen
et al., 2009), and cell viability were measured near the end
of hepatic parasite development, at 48h post-infection (hpi).
Our results show that an increase in glucose availability corre-
lates with an increase of overall Plasmodium infection
(Fig. 1A). In contrast, any glucose concentration below the
standard medium≈10mM concentration significantly impairs
infection (Fig. 1A), demonstrating that glucose is required for
a successful hepatic Plasmodium infection. Cell viability was
not affected by the presence of an excess of glucose in the
medium, but decreased for 2.5 and 1.25mM of glucose
(Fig. 1A). Crucially, decreasing the glucose concentration from
10 to 5mM significantly decreases parasite load but has no
impact on cell viability.
In order to dissect how glucose influences hepatic infec-
tion, we employed an established flow cytometry-based ap-
proach that makes use of green fluorescent protein (GFP)-
expressing P. berghei parasites to determine the number
of infected cells and to measure parasite development
(Prudencio et al., 2008). The analysis of cells 2h after sporo-
zoite addition, when the invasion process is virtually com-
pleted (Prudencio et al., 2008), shows that glucose
concentration does not affect the ability of parasites to tra-
verse (data not shown) or invade (Fig. 1B) cells. Conversely,
when cells were analysed 48hpi, a glucose-dependent in-
crease in parasite development was observed (Fig. 1C).
These results also showed that the number of infected cells
is higher at 20mM glucose concentration, and lower at glu-
cose concentrations below the physiological range, sug-
gesting that glucose availability influences the survival of
infected cells. These results were further confirmed by im-
munofluorescence microscopy analysis, which demon-
strated that parasite size is proportional to the amount of
glucose in the medium and that the survival of liver stage
parasites 48 hpi depends on the availability of glucose
(Fig. 1D, E). In fact, at low glucose concentrations, not only
are most parasites very small (<50μm2) but also the num-
ber of infected cells is very low. Increasing concentrations
of glucose lead to higher numbers of parasites and favour
parasite growth, with approximately 40%of the parasites be-
ing larger than 200μm2 at 10 and 20mM glucose (Fig. 1E).
Whereas hepatoma cells are highly dependent on glucose
uptake for ATP production through glycolysis (Warburg
et al., 1927; Kroemer andPouyssegur, 2008), primary hepato-
cytes are able to store glucose as glycogen and use oxidative
phosphorylation to produce ATP. Accordingly, the require-
ments for glucose uptake by primary hepatic cells are signifi-
cantly lower than those displayed by tumorigenic cells
(O’Neil et al., 2005). In agreement with this, we showed that
the decreased cell viability noted in hepatoma cells at 2.5
and 1.25mM glucose was not observed in primary
hepatocytes, even upon complete removal of glucose.
Crucially, however, our data also clearly show that overall
infection of mouse primary hepatocytes by P. berghei is
significantly decreased in the absence of glucose in the
medium (Fig. S1). Overall, these results demonstrate that glu-
cose availability plays a crucial role in the liver stage
development and survival of Plasmodium parasites.
Glucose uptake is specifically increased in hepatic cells
containing replicating P. berghei parasites
Having demonstrated a requirement for glucose during liver
stage P. berghei development, we then sought to determine
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whether glucose uptake is specifically enhanced in infected
cells and whether this is linked to parasite replication within
these cells. To this end, we monitored by flow cytometry
the uptake of a fluorescent glucose derivative, 2-NBDG
(2-deoxy-2-[(7-nitro-2,1,3-benzoxadiazol-4-yl)amino]-D-glu-
cose) (O’Neil et al., 2005; Yamada et al., 2007) by P.
berghei-infected cells. Huh7 cells were incubated with
2-NBDG and analysed at different time points following
addition of red fluorescence protein (RFP)-expressing P.
berghei sporozoites. The uptake of 2-NBDG was measured
as an increase in green fluorescence intensity, whereas
parasite development was monitored as a function of red
fluorescence intensity. The latter enables the population of
cells containing replicating parasites to be distinguished
from a smaller population of cells containing parasites that
do not develop in vitro (Prudencio et al., 2008) (Fig. S2).
Our results clearly show that glucose uptake is highly
increased in cells containing developing parasites, from
30 hpi onwards (Fig. 2A). A smaller increase in glucose
uptake is also observed at around the same time in
non-infected cells and in cells containing non-developing
parasites, present in the same well (Fig. 2A). Live fluores-
cence microscopy analysis of non-infected and infected
Huh7 cells 48hpi (Fig. S3A) confirmed that 2-NBDG fluores-
cence intensity is significantly higher in infected than in
non-infected cells (Fig. S3B) and further revealed the uptake
of 2-NBDG by the developing parasite (Fig. S3B).
Because it is known that glucose uptake may be
influenced by factors such as feeding/fasting, exposure to
low/high temperature, exercise, oxidative stress, several
liver pathologies, such as steatosis and non-alcoholic fatty
liver disease and liver infections, for example, by hepatitis
C virus (Cunningham et al., 1985; Pencek et al., 2004; Bitar
et al., 2005; Bechmann et al., 2012; Moore et al., 2012;
Vidyashankar et al., 2012; Yu et al., 2013), we sought to as-
sess the specificity of theP. berghei-induced increase in glu-
cose uptake by infected Huh7 cells. To this end, we
measured 2-NBDGuptake by Huh7 cells subjected to condi-
tions known to induce low-temperature stress in various
types of mammalian cells (Fujita, 1999), high-temperature
Fig. 1. Glucose availability impacts P. berghei hepatic infection.
A. Huh7 cells were infected with luciferase-expressing P. berghei sporozoites, and the culture medium was replaced 2 hpi by medium with different
concentrations of glucose. Parasite load (luminescence) and cell viability were assessed after 48 h. Representative experiment out of two independent
experiments. Error bars represent standard deviation (SD). One-way analysis of variance (ANOVA) with post-test Dunnett.
B. The culture medium of Huh7 cells was replaced by medium with different concentrations of glucose 1 h prior to infection with green fluorescent protein
(GFP)-expressing sporozoites. Cell invasion was quantified by determining the percentage of GFP+ cells 2 hpi by flow cytometry. Representative
experiment out of two independent experiments. Error bars represent SD. One-way ANOVA with post-test Dunnett.
C. Huh7 cells were infected with GFP-expressing P. berghei sporozoites, and the culture medium was replaced 2 hpi by medium with different
concentrations of glucose. Parasite development and the total number of infected cells were assessed by flow cytometry by determining the fluorescence
intensity and the number of GFP+ cells at 48 hpi, respectively. Representative experiment out of five independent experiments. Error bars represent SD.
One-way ANOVA with post-test Dunnett.
D. Representative confocal images of Huh7 cells infected with sporozoites and incubated in medium with different concentrations of glucose for 48 h.
Cells were immunostained with anti-UIS4 (red), which localises to the parasitophorous vacuole membrane, anti-heat shock protein (HSP)70 (green),
which localises to the parasite’s cytoplasm, and Hoechst (blue), a nuclear stain. Scale bar, 10 μm.
E. For each glucose concentration, the exoerythrocytic forms in the fluorescence microscopy images acquired were counted, and their area was
determined. Exoerythrocytic formswere divided into five different size classes. Pool of two independent experiments. Chi-square test. ns, not significant; *
P< 0.05, ** P< 0.01 and *** P< 0.001.
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stress in a chicken hepatocellular carcinoma cell line (Sun
et al., 2015) or oxidative stress in rat hepatocytes (Sergent
et al., 2005; Nourissat et al., 2008) (Fig. 2B). Finally, we in-
fected Huh7 cells with murine gammaherpesvirus 68
(MHV-68) (Collins et al., 2009), and measured 2-NBDG up-
take at 24hpi and at different infection loads (Fig. 2C). The
efficacy of infection was confirmed by flow cytometry
employing YFP-expressing MHV-68 in a parallel experiment
(Fig. S4). Our data clearly show that there was little or no
effect on 2-NBDG uptake into the cells by any of the
stress-inducing treatments employed, or by viral infection.
This indicates that the increase in glucose uptake by P.
berghei-infected cells is not the result of a non-specific
response to stress or to infection (Fig. 2B, C). Overall, our re-
sults show thatP. berghei development insideHuh7 leads to
a specific and marked enhancement of glucose uptake by
these cells. The observed effect appears rather unique to
malaria parasites, as other intracellular pathogens, such as
Toxoplasma gondii do not depend on host-derived glucose
(Blume et al., 2009), and hepatitis C virus replication actually
suppresses cellular glucose uptake through down-
regulation of cell surface expression of glucose transporters
(Kasai et al., 2009).
RNA interference screen implicates GLUT1 in glucose
uptake by P. berghei-infected hepatic cells
The results so far suggest that infection of hepatic cells by
Plasmodium modulates the uptake of glucose by these cells,
possibly through the enhancement of the activity of
Fig. 2. Glucose uptake is specifically increased in hepatoma cells containing developing P. berghei parasites.
A. 2-NBDG uptake by different cell populations, normalised to cell size, at different time points of infection, assessed by flow cytometry. Error bars
represent standard deviation. Two-way analysis of variance (ANOVA) with post-test Bonferroni.
B. 2-NBDG uptake by naïve Huh7 cells, cells containing developing P. berghei parasites at 48 hpi, and cells subjected to low-temperature,
high-temperature and ethanol-induced oxidative stresses, assessed by flow cytometry. Pool of two independent experiments. Error bars represent
standard deviation. One-way ANOVA with post-test Dunnet.
C. 2-NBDG uptake by naïve Huh7 cells and cells infected with MHV-68 at different multiplicity of infection, assessed by flow cytometry. Pool of two
independent experiments. Error bars represent Standard error of themean (SEM). One-way ANOVAwith post-test Dunnet. ns, not significant; **P< 0.01
and *** P< 0.001. PFU, plaque-forming unit.
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membrane glucose transporters in the cell. To ascertain this,
we decided to carry out a small-scale RNA interference (RNAi)
screen to evaluate the effect of the down-regulation of the ex-
pression of 5 transmembrane glucose transporters upon P.
berghei infection (Table S1). The screen included all class I
GLUT genes (GLUT1-4) as well as GLUT9, a major regulator
of influx in HepG2 hepatoma cells (Takanaga et al., 2008).
Huh7 cells stably expressing shRNA sequences targeting
the selected genes were constructed to be used throughout
the RNAi screen. The screen proceeded in three consecutive
steps, employing different established methods to measure
hepatic infection by P. berghei. In the first step of the screen,
three shRNA sequences were used to silence each of the se-
lected genes and the resulting stable cell lines were infected
with luciferase-expressingP.berghei sporozoites. Forty-eighth
later, the parasite load in these cells was determined by mea-
suring the bioluminescence of cell lysates. Each sequence
was used in at least four independent experiments, and an
shRNA targeting Scavenger receptor class B type I (SR-BI)
was employed as a positive control for infection decrease, as
this receptor has been implicated in hepatic cell invasion by
P. berghei parasites (Rodrigues et al., 2008). GLUT1 emerged
as the genewhose knock-down (KD) leads to the strongest de-
crease in infection (Fig. 3A), withGLUT4 andGLUT9KD yield-
ing a more moderate effect (Fig. 3A). We then carried out the
second step of the RNAi screen, where only GLUT1, GLUT4
and GLUT9 were silenced prior to infection with GFP-
expressing P. berghei parasites. The extent of parasite devel-
opment was assessed 48h later by flow cytometry determina-
tion of GFP intensity (Prudencio et al., 2008). The results
showed that KD of GLUT1 leads to the strongest impairment
of parasite development among the three genes assessed
(Fig. 3B). Therefore, GLUT1 was selected for the final confir-
mation screening step using the three different shRNA se-
quences targeting the GLUT1 gene and assessing parasite
development by immunofluorescence microscopy (Fig. 3C).
Interestingly, the imaging data demonstrated that parasite size
correlates with the mRNA levels of GLUT1, suggesting that
GLUT1-mediated glucose uptake is required for the parasite’s
development (Fig. 3C and Table S1).
To further establish a link between the uptake of glucose by
GLUT1 and Plasmodium infection, we assessed the differ-
ence in 2-NBDG uptake between infected and non-infected
Huh7 cells expressing the same three GLUT1-targeting
shRNA sequences as earlier. This difference was drastically
reduced in the GLUT1-KD stable cell lines, relative to
scramble-transduced control cells, a decrease that is propor-
tional to the extent of the down-modulation of GLUT1
(Fig. 3D). As an additional control, we assessed 2-NBDG up-
take following KD of GLUT2, whose expression by Huh7 cells
we confirmed (2.6± 0.8-fold lower than GLUT1), and can
therefore contribute to glucose uptake by these cells. Never-
theless, our results showed that, contrary to GLUT1 the
down-modulation of the expression of GLUT2 does not affect
2-NBDG uptake by cells containing developing parasites
(Fig. 3D). We also confirmed that GLUT1 KD does not affect
glucose uptake by non-infected cells except for a small de-
crease in cells where the down-modulation of GLUT1 expres-
sion is most pronounced (Fig. S5).
Finally, we assessed infection, as well as 2-NBDG uptake
by infected cells, in the presence ofWZB117, a specific inhib-
itor of GLUT1-mediated glucose transport (Liu et al., 2012).
Our results provide a chemical validation of the genetic ap-
proach (Fig. 3), as they show a clear dose-dependent effect
of WZB117 on overall P. berghei infection of Huh7 cells
(Fig. 4A), on parasite development (Fig. 4B), and on the dif-
ference in 2-NBDG uptake between cells infected with devel-
oping parasites and non-infected cells (Fig. 4C). Additionally,
we showed that P. berghei infection of mouse primary hepa-
tocytes is significantly impaired by the addition of 100μM
WZB117 to the cell culture medium (Fig. S6). Most impor-
tantly, intra-peritoneal administration of WZB117 to mouse
models of Plasmodium infection significantly decreases the
parasite load in the livers of P. berghei-infected mice relative
to vehicle-treated control animals (Fig. 4D). Immunofluores-
cence microscopy analysis of liver sections of these mice
(Fig. 4E) revealed a significant decrease in parasite areas
(Fig. 4F) and numbers (Fig. 4G) in WZB117-treated animals.
These results indicate that GLUT1 inhibition by WZB117
leads to the inhibition of the hepatic parasite’s development,
as well as to its decreased survival in vivo.
GLUT1 expression is not enhanced in Plasmodium-infected
cells
Having established a role for GLUT1 in the specific uptake of
glucose by infected cells, we hypothesised that Plasmodium
infection might lead to an increase in the expression of that
transporter. To address this, we compared GLUT1 expres-
sion levels in non-infected and infected Huh7 cells at 6, 30
and 48 hpi with GFP-expressing P. berghei parasites.
Following the separation of infected and non-infected cells
by fluorescence-activated cell sorting (FACS) (Albuquerque
et al., 2009), cells were analysed by quantitative real-time
polymerase chain reaction (qPCR), employing GLUT1-
specific primers (Table S2). The data showed no significant
differences in GLUT1 expression between infected and non-
infected cells, at the selected time points (Fig. S7). As such,
we concluded that the increase in GLUT1-mediated glucose
uptake byPlasmodium-infected cells does not result from an
infection-induced enhancement of the mRNA expression of
this transporter.
P. berghei development leads to cytoplasmic ATP depletion
It has been shown that GLUT1 has a cytoplasmic pocket
that is postulated to allow the binding of ATP, which in turn
induces conformational changes that inhibit GLUT1-
mediated glucose transport (Cloherty et al., 1996; Levine
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et al., 1998). This modulation of GLUT1 conformation by
ATP is counteracted by the binding of Adenosine
monophosphate (AMP) and Adenosine diphosphate (ADP)
to the same site in GLUT1 (Blodgett et al., 2007). We thus
wondered whether the observed increase in glucose uptake
by Plasmodium-infected cells would correlate to a decrease
inATP levels in these cells. To investigate this, we employed
a fluorescence resonance energy transfer-based indicator
for ATP (ATeam), composed of the ε subunit of the bacterial
FoF1-ATP synthase sandwiched between the cyan-
fluorescent proteins and Venus fluorescent proteins (CFP
andVenus, respectively), which enablesmeasurement of in-
tracellular ATP levels as a function of the Venus/CFP ratio
(Imamura et al., 2009). Using RFP-expressing P. berghei
parasites and live fluorescence microscopy, we specifically
monitored ATP levels in non-infected and infected cells at
30 and 48hpi. Interestingly, we observed that the ATP levels
of infected cells were significantly lower than those of naïve
cells (Fig. 5A). In agreementwith the results in Fig. 2A, which
show that non-infected cells take up more 2-NBDG than
naïve cells, we also detected a smaller but significant ATP
reduction in the non-infected cells (Fig. 5A), when compared
with naïve cells. These data indicate that liver stage parasite
development results in a decrease in the ATP available
inside the host cell, presumably leading to the
well-described ATP/ADP/AMP-driven conformational
Fig. 3. GLUT1 knockdown significantly impairs P. berghei liver stage development and glucose uptake by P. berghei-infected cells.
A. Huh7 cells with stable knockdown of one of fiveGLUT receptors were infected with luciferase-expressingP. berghei sporozoites and parasite loadwas
assessed by luminescencemeasurement 48 h later. A scrambled shRNA sequencewas used as a negative control and a cell line with stable knockdown
of SR-BI as positive control. Pool of four independent experiments. Error bars represent SEM.
B. Huh7 cells with the knockdown of GLUT1, GLUT4 or GLUT9 were infected with green fluorescent protein (GFP)-expressing P. berghei sporozoites.
The percentage of infected cells and parasite development were assessed by flow cytometry at 48 hpi. Pool of three independent experiments. Error bars
represent SEM.
C. Quantification of the area of the EEFs in each of the three different cell lineswith GLUT1 knockdown at 48 hpi by immunofluorescencemicroscopy. The
knockdown efficiency of each shRNA sequence is indicated. Pool of three independent experiments.
D. Difference of 2-NBDGuptake in the several cell lines with GLUT1 knockdown by developing parasites-containing cells and non-infected cells at 48 hpi,
assessed by flow cytometry. A cell line with the knockdown of GLUT2 was used as control. Pool of four independent experiments. Error bars represent
SEM. All panels: one-way analysis of variance (ANOVA) with post-test Dunnett. ns, not significant, * P< 0.05, ** P< 0.01 and *** P< 0.001.
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changes inGLUT1 (Cloherty et al., 1996; Levine et al., 1998;
Blodgett et al., 2007).
P. berghei infection leads to GLUT1 translocation to the
plasma membrane
In order to compare the amount of GLUT1 present on the
surface of infected and non-infected cells, Huh7 cells were
infected with RFP-expressing P. berghei parasites and
incubated with the fusion peptide HRBD-EGFP (consisting
of the Receptor Binding Domain of the human T cell leukae-
mia virus fused to enhanced green fluorescent protein),
which has been shown to specifically bind to GLUT1 at the
extracellular surface of the cell plasma membrane (Manel
et al., 2003; Kinet et al., 2007). CoCl2 was used as a positive
control as it has been shown to enhance GLUT1 transloca-
tion to the plasma membrane (Koseoglu and Beigi, 1999).
Flow cytometry analysis showed a similar increase in the
amount of plasma membrane-located GLUT1 in both
non-infected and infected cells at 30 hpi, relative to naïve
cells (Fig. 5B). However, at 48hpi, the amount of GLUT1 at
the cell surface is specifically and significantly enhanced in
infected cells (Fig. 5B), an increase whose magnitude is
consistent of that observed upon stimulation of Rat2 cells
by 12-O-tetradecanoyl-phorbol-13-acetate (TPA) (Lee
et al., 2015). Our results suggest that an enhancement of
GLUT1 availability at the plasma membrane facilitates the
uptake of glucose required for the later stages of parasite de-
velopment, the time at which there is a dramatic increase in
Fig. 4. Chemical inhibition of GLUT1-mediated glucose transport by WZB117 affects P. berghei hepatic infection in vitro (A-C) and in vivo (D-G).
A. Huh7 cells were infected with luciferase-expressing P. berghei sporozoites and 2 h later the culture medium was replaced by medium with increasing
concentrations of WZB117. Parasite load (luminescence) and cell viability were assessed at 48 hpi. Representative experiment out of two independent
experiments. Error bars represent standard deviation (SD). One-way analysis of variance (ANOVA) with post-test Dunnett.
B. Huh7 cells were infected with red fluorescent protein-expressing P. berghei sporozoites and 2 h later the culturemediumwas replaced by mediumwith
increasing concentrations of WZB117. Parasite development was assessed by flow cytometry at 48 hpi. Pool of two independent experiments. Error bars
represent SD. One-way ANOVA with post-test Dunnett.
C. 2-NBDG uptake by red fluorescent protein-expressing P. berghei-infected cells at 48 hpi after treatment with increasing concentrations of WZB117,
assessed by flow cytometry. Pool of two independent experiments. One-way ANOVA with post-test Dunnett.
D. C57BL/6 mice received three doses of 10mg/kg of WZB117 i.p., the first immediately before infection with P. berghei sporozoites and the other two at
15 and 30 hpi. Parasite load was assessed at 44 hpi by qPCR. Pool of three independent experiments. Vehicle: n = 15 mice; WZB117-treated: n = 12
mice. Two-tailed Mann–Whitney test.
E. Fifty μm sections of one liver lobe from one mouse of each experimental group were stained with anti-UIS4 (white), anti-GFP (green), phalloidin (red)
and Hoechst (blue). Representative confocal images of P. berghei parasites in both experimental groups of mice. Scale bar, 10 μm.
F. Area of the parasites in the control (vehicle) or the WZB117-treated mouse, determined by immunofluorescence microscopy. Representative
experiment out of two independent experiments. Two-tailed Mann–Whitney test.
G. Number of parasites per area of liver in control andWZB117-treated mice. Representative experiment out of two independent experiments. Error bars
represent SD. Two-tailed Mann–Whitney test. ns, not significant; * P< 0.05, ** P< 0.01 and *** P< 0.001.
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glucose uptake (Fig. 2A). Overall, our data support the
notion that increased glucose uptake by P. berghei-infected
hepatic cells is mediated by GLUT1, which becomes
activated by the ATP depletion and translocated into the
membrane of the infected cell (Fig. 6).
Discussion
Plasmodium parasites require large amounts of nutrients for
their extensive replication inside liver cells. Here, we show
that glucose uptake is significantly increased in infected he-
patic cells, through the enhanced action and translocation of
the GLUT1 membrane transporter.
Glucose is ubiquitously used as the common currency of
metabolism, and the ability to transport this hexose across
the plasma membrane is a feature of nearly all cells
(Mueckler, 1994). Although GLUT2 is the major glucose
transporter of hepatocytes, where it is involved in glucose
uptake and release in the fed and fasted states, respectively
(Thorens et al., 1990; Mueckler and Thorens, 2013), GLUT1
is also present in the liver (Karim et al., 2012), where it is
transcribed and expressed by both periportal and
perivenular hepatocytes. Of note, GLUT2 has a high
capacity but a low affinity for glucose, with a Km value (the
concentration of glucose at which transport is half of its
maximal value) in the order of 17mM (Uldry et al., 2002).
GLUT1, on the other hand, has a higher affinity for glucose
with a Km value of ~3mM (Uldry et al., 2002), which is closer
to that of PfHT (~1mM, (Woodrow et al., 2000)). Thus, it is
tempting to speculate that GLUT1 is better matched to
Fig. 6. Proposed model of GLUT1-mediated glucose uptake during hepatic infection by Plasmodium. Following the invasion of hepatic cells by
Plasmodium parasites and the establishment of infection (left), parasites initiate a process of dramatic intracellular replication. Parasite development
reduces the amount of host intracellular glucose, leading to depletion of the ATP pool and binding of ADP/AMP to GLUT1 transporters at the plasma
membrane. This results in their activation (middle). At later stages of infection, GLUT1 transporters present in the host cell’s cytoplasmic compartments
are translocated to the cell membrane, leading to further enhancement of glucose uptake (right).
Fig. 5. P. berghei development inside Huh7 cells results in a decreased ATP/AMP ratio and increased GLUT1 content at the plasma membrane.
A. Huh7 cells were transfected with an ATP probe, AT1.03, and infected with red fluorescent protein-expressingP. berghei sporozoites. Thirty and 48 hpi,
the Venus/cyan-flourescent proteins (CFP) emission ratio in the cytoplasm of each individual cell (non-infected and cells containing developing parasites)
was calculated from the fluorescent images acquired in both channels. Huh7 cells incubated in RPMI without glucose with 10mMof galactose and 10 μM
of Oligomycin were used as positive controls for ATP depletion. Pool of 2 and 3 independent experiments for the 30 and 48 h time points, respectively.
B. Huh7 cells were infected with red fluorescent protein-expressing sporozoites and, at 30 and 48 hpi, were incubated with the HRBD-EGFP peptide that
binds specifically toGLUT1 at the surface of the cells andwere analysed by flow cytometry. Huh7 cells incubated overnight in completeRPMIwith 250 μM
of CoCl2 were used as positive controls. Pool of 2 and 4 independent experiments for the 30 and 48 h time points, respectively. Error bars represent SEM.
Both panels: one-way ANOVA with post-test Tukey. ns, not significant; * P< 0.05 and *** P< 0.001.
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supply glucose to the parasite, especially if local glucose
concentrations decrease towards the Km of GLUT1.
Interestingly, despite being expressed by all hepatocytes,
membrane localization of GLUT1 under basal conditions is
restricted to hepatocytes proximal to the hepatic venule
(Tal et al., 1990; Thorens et al., 1990; Bilir et al., 1993; Karim
et al., 2012; Mueckler and Thorens, 2013). Because the liver
cell plate is perfused unidirectionally from portal to hepatic
venule, the concentration of several substrates, such as
oxygen and glucose, decreases as blood moves closer to
the latter (Bilir et al., 1993). This is consistent with the
observation that GLUT1 expression is enhanced by a
decrease in circulating glucose levels (Simpson et al.,
1999) as well as by hypoxia (Ebert et al., 1995). Importantly,
it has recently been shown that hypoxia enhances liver
stage infection by malaria parasites, an effect that is also
observed following treatment with an activator of hypoxia
inducer factor-1α (HIF-1α) or with the hypoxia mimetic CoCl2
(Ng et al., 2014). Interestingly, increased HIF-1α levels have
been shown to upregulate expression of GLUT1 (Chen
et al., 2001) and CoCl2 has been shown to enhance GLUT1
translocation to the plasma membrane ((Koseoglu and
Beigi, 1999) and Fig. 5B). In this context, our results suggest
that GLUT1-mediated glucose transport may provide a cru-
cial link to explain the observed preferential infectivity of hyp-
oxic liver cells by Plasmodium parasites.
The data presented here is consistent with our proposed
model (Fig. 6), in which the extensive replication of liver
stage parasites promotes the depletion of intracellular glu-
cose and, consequently, of ATP. This effect is compensated
for by an increase in glucose uptake that results from (i) the
likely activation of GLUT1 transporters at the plasma mem-
brane via AMP-dependent conformational changes and (ii)
from GLUT1 translocation to the plasma membrane,
particularly towards the end of parasite development. The
significant increase in glucose uptake by infected cells likely
leads to a decrease in glucose availability in the vicinity of
infected cells, which may result in a similar, albeit weaker,
response by neighbouring non-infected cells. In fact, these
cells also display a small decrease in ATP levels, as well
as some, although not statistically significant, GLUT1
translocation to the membrane (Fig. 5A,B), and a slight
increase in glucose uptake from 30hpi onwards (Fig. 2A).
A question that remains open is which mechanism(s) is
(are) involved in regulating GLUT1 activation and transloca-
tion into the membrane of the infected cell. It has previously
been shown that enhanced glucose transport by GLUT1
transporters preexisting in the plasma membrane is associ-
ated with stimulation of AMP-activated protein kinase
(AMPK) activity (Abbud et al., 2000; Barnes et al., 2002).
On the other hand, it has been shown that GLUT1 transloca-
tion to the plasma membrane may be triggered by insulin
(Egert et al., 1999), in a phosphoinositide 3-kinase(PI3K)-
dependent fashion (Egert et al., 1999; Perrini et al., 2004).
Intriguingly, neither parasite development nor glucose up-
take by P. berghei-infected cells seem to be affected by
the down-regulation of either the α1 and the α2 subunits of
AMPK (Fig. S8). Likewise, addition of insulin or inhibition of
PI3K with Wortmannin (Nagai et al., 2011; Hsu and Yang,
2014) do not impact infection or glucose uptake by infected
cells (Fig. S9). Very recently, phosphorylation of GLUT1 by
protein kinase C has been shown to lead to the rapid in-
crease in glucose uptake and enhanced cell surface locali-
zation of GLUT1 induced by TPA (Lee et al., 2015).
Whether a similar mechanism may be at play during P.
berghei infection of hepatic cells is currently under
investigation.
Despite the fact that, under basal conditions, GLUT1 is
only localised at the membrane of perivenous hepatocytes,
we showed that in vivo chemical inhibition of GLUT1-
mediated glucose uptake has a substantial impact on the
number of P. berghei-infected hepatocytes. There are two
possible explanations for this observation. The first is that
the inhibitor only hinders GLUT1-mediated glucose uptake
on perivenous hepatocytes and, therefore, only has an effect
on the parasites inside these hepatocytes. Alternatively, in
accordance with our model, the replication of the parasite
inside periportal hepatocytes could lead to a depletion of
the cellular glucose pool and trigger the translocation of
GLUT1 present in the endoplasmic reticulum (ER), Golgi
and endosomal compartiments to the plasma membrane,
thereby increasing the percentage of infected hepatocytes
with GLUT1 at the plasma membrane and, therefore, the
number of cells targeted by the inhibitor.
The (East Rutherford, NJ, USA) liver displays the capacity
to remove 30–40% of the glucose presented to it following
glucose ingestion and thereforemust be considered a signif-
icant site of postprandial glucose removal (Pagliassotti and
Cherrington, 1992). Interestingly, a recent case–control
study in Ghana found that patients with type 2 diabetes
mellitus had a 46% increased risk for infection with P.
falciparum (Danquah et al., 2010). The authors of this study
offer a number of possible explanations for this observation,
including impaired immune responses, an increased num-
ber of infectious mosquito bites, and enhanced parasite
growth in the blood of type 2 diabetes mellitus patients
(Danquah et al., 2010). Thus, our results suggest the possi-
bility that the elevated amounts of circulating glucose
displayed by diabetic patientsmay also promote parasite de-
velopment in the liver, thereby contributing to the increased
risk of appearance of clinically relevant malaria. Further in-
vestigation of the link between diabetes and malaria is
clearly warranted by the fact that sub-Saharan Africa cur-
rently faces the world’s highest increase in type 2 diabetes
mellitus (Wild et al., 2004).
To the best of our knowledge, this is the first report that
addresses the role of glucose during hepatic infection by
Plasmodium from a molecular point of view. It identifies
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GLUT1 as a druggable target and a major player in glucose
uptake by infected cells and shows that its function as a
glucose transporter is modulated in cells containing replicat-
ing parasites. These findings contribute to an understanding
of how hepatic host cellsmeet the energy demands imposed
by the parasite’s huge replication rate. Such an understand-
ing may help identify strategies to control energy production
by infected cells and thereby limit parasite development and
survival.
Experimental procedures
Chemicals
Roswell Park Memorial Institute (RPMI) 1640, PBS pH7.4, trypsin,
fetal bovine serum (FBS), non-essential amino acids,
penicillin/streptomycin, glutamine, HEPES pH 7, OptiMEM and
Lipofectamine RNAiMAX were purchased from Gibco-Thermo
Fisher Scientific (Waltham, MA USA). All other chemicals were ob-
tained from Sigma-Aldrich (St. Louis, MO, USA), unless otherwise
specified.
Cells
Huh7 cells, a human hepatoma cell line, were cultured inRPMI 1640
medium supplemented with 10% v/v FBS, 0.1 mM non-essential
amino acids, 50μg/ml penicillin/streptomycin, 2mM glutamine and
1mM HEPES (final concentrations), pH 7 and maintained at 37 °C
with 5%CO2. Mouse primary hepatocytes were cultured inWilliam’s
E medium supplemented with 4% FBS, 2mM glutamine, 1mM
HEPES and 50 μg/ml penicillin/streptomycin, and maintained at
37 °C with 5% CO2.
Mice
C57BL/6 mice were purchased from Charles River (Lyon, France)
and housed in the rodent facility of Instituto de Medicina Molecular
(Lisbon, Portugal). All animal experiments were performed in strict
compliance to the guidelines of our institution’s animal ethics
committee and the Federation of European Laboratory Animal
Science Associations (FELASA).
Parasites
Green fluorescent protein (GFP)-expressing, red fluorescent protein
(RFP)-expressing, or luciferase-expressing P. berghei ANKA
sporozoites were dissected in non-supplemented RPMI medium
from the salivary glands of infected femaleA. stephensimosquitoes,
bred at Instituto de Medicina Molecular, prior to being employed
for in vitro and in vivo infections (Franke-Fayard et al., 2004;
Ploemen et al., 2009).
Overall in vitro infection by luminescence
Overall hepatic infection was determined bymeasuring the lumines-
cence intensity in Huh7 cells or mouse primary hepatocytes infected
with a firefly luciferase-expressing P. berghei line, as previously
described (Ploemen et al., 2009). Briefly, Huh7 cells or mouse
primary hepatocytes (1.0 × 104 and 2.0 × 104 per well, respectively)
were seeded in 96-well plates the day before infection. Sporozoite
addition was followed by centrifugation at 1800 × g for 5min and
the medium was replaced approximately 2 hpi by the appropriate
medium. Parasite infection load was measured 48hpi by a biolumi-
nescence assay (Biotium, Hayward, CA, USA) using a multiplate
reader Infinite M200 (Tecan, Männedorf, Switzerland). The effect
of the different treatments on cell viability was assessed by the
CellTiter-Blue assay (Promega, Fitchburg, WI, USA) according to
the manufacturer’s protocol.
Quantification of P. berghei invasion and development by
flow cytometry
Invasion of hepatoma cells and intracellular parasite development
were assessed by determining the percentage of GFP+ cells 2 hpi
with a GFP-expressing P. berghei line and by measuring the inten-
sity of the GFP signal of the infected cells 48 hpi, respectively, as
previously described (Prudencio et al., 2008). Huh7 cells (5.0 × 104
per well) were seeded in 24-well plates the day before infection.
The medium was replaced by the appropriate medium 1 h prior or
2 hpi, for invasion and development quantification, respectively.
Cells were then collected for flow cytometry analysis at 2 h or
48 hpi, respectively, and analysed on a BD Biosciences
FACScalibur (BD Biosciences, Franklin Lakes, NJ, USA). Data ac-
quisition and analysis were carried out using the CELLQUEST (version
3.1.1 f1, BD Biosciences) and FLOWJO (version 6.4.7, Ashland, OR,
USA) software packages, respectively.
Immunofluorescence imaging of P. berghei in Huh7 cells
For immunofluorescence microscopy analyses, cells were seeded
on glass coverslips in 24-well plates and infected with sporozoites
as described earlier. Forty-eight hpi, cells were rinsed with 1x PBS
and fixedwith 4%v/v paraformaldehyde (SantaCruz Biotechnology,
Dallas, TX, USA) for 20min at room temperature and stored at 4 °C
in PBS 1x until being stained. Cells were incubated with the
permeabilization/blocking solution (0.1% v/v Triton X-100, 1% w/v
bovine serum albumin in 1x PBS) for 30min at room temperature.
Parasites were stained with a parasite specific anti-Heat shock pro-
tein 70 (Hsp70) antibody (2E6; dilution 1:100) and an anti-UIS4 an-
tibody (dilution 1:1000) for 1 h at room temperature, followed by
threewasheswith permeabilization/blocking solution. Cellswere fur-
ther incubated in a 1:400 dilution of anti-mouse Alexa-Fluor 488
(Jackson ImmunoResearch Laboratories, West Grove, PA, USA)
or anti-goat Alexa-Fluor 568 (Life Technologies, Carlsbad, CA,
USA) secondary antibodies in the presence of a 1:1000 dilution of
Hoechst 33342 (Invitrogen, Carlsbad, CA, USA) for nuclei staining.
An additional three washes were carried out with permeabilization/
blocking solution. Coverslips were mounted on microscope slides
with Fluoromount (SouthernBiotech, Birmingham, AL, USA). Confo-
cal images were acquired using a Zeiss LSM 710 confocal micro-
scope (Carl Zeiss, Oberkochen, Germany). Widefield images for
size determination were acquired in a Zeiss Axiovert 200M micro-
scope (Carl Zeiss, Oberkochen, Germany). Imageswere processed
with IMAGEJ software (version 1.47, NIH, Bethesda, MD, USA).
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Quantification of glucose uptake by flow cytometry and live
microscopy
Glucose uptake into Huh7 cells was quantified by flow cytometry
using a fluorescent D-glucose derivative, 2-[N-(7-nitrobenz-2-oxa-
1,3-diazol-4-yl)amino]-2-deoxy-D-glucose (2-NBDG; Molecular
Probes, Life Technologies) as a tracer (O’Neil et al., 2005; Yamada
et al., 2007). Briefly, Huh7 cells (1.0 × 104 per well) were seeded in
96-well plates the day before infection with RFP-expressing P.
berghei sporozoites. At several time points after infection, the
medium was replaced by RPMI without glucose supplemented with
1mM of glucose and 0.1mM of 2-NBDG, and cells were incubated
for 5min at 37 °C to allow uptake (O’Neil et al., 2005). Cells were
then collected for flow cytometry analysis and analysed on a BD
LSR Fortessa flow cytometer (BD BIOSCIENCES, Franklin Lakes, NJ,
USA) with the DIVA software (version 6.2, BD BIOSCIENCES, Franklin
Lakes, NJ, USA). Analysis was carried out using the FLOWJO soft-
ware (version 6.4.7, FlowJo). For live microscopy, Huh7 cells
(2.0 × 105) were seeded on glass bottom microwell dishes (MatTek,
Ashland, MA, USA) the day before infection with RFP-expressingP.
berghei sporozoites. At 48 hpi, the medium was replaced by RPMI
without glucose supplemented with 1mM of glucose and 0.1 mM
of 2-NBDG, and cells were incubated for 30min at 37 °C. Cells were
then visualised on a 3i Marianas SDCmicroscope and the acquired
images were processed with IMAGEJ software (version 1.47).
Temperature shocks and ethanol-induced oxidative stress
Huh7 cells (1.0 × 104 per well) were seeded in 96-well plates and
incubated at 37 °C for 48 h. To induce a mild cold stress response,
one of the plates was incubated at 27 °C for 1 h (Fujita, 1999). To
induce a heat stress response, another plate was incubated at
43 °C for 1 h (Sun et al., 2015). A control plate was maintained at
37 °C. Ethanol-induced oxidative stress was attained by incubating
Huh7 cells in complete RPMI with 50mM of ethanol for 24 h
(Sergent et al., 2005; Nourissat et al., 2008). Following temperature
shocks and ethanol-induced oxidative stress, the uptake of
2-NBDG by the cells was determined as previously described.
Viral infection-induced stress
Huh7 cells (5.0 × 104 per well) were seeded in 24-well plates and, on
the following day, were infected with 0.01, 1 and 5 plaque-forming
units/cell of wild type murine gammaherpesvirus 68 (MHV-68) or
YFP-expressing MHV-68 (MHV-68-YFP) (Collins et al., 2009).
Twenty-four h later, the uptake of 2-NBDG by the MHV-68-infected
cells was determined as previously described. The percentage of
MHV-68-infected cells in each condition was estimated by
determining the percentage of YFP+ cells after infection with the
same amount of plaque-forming units/cell of MHV-68-YFP.
Assessment of the impact of glucose transporters on
Plasmodium infection by RNA interference (RNAi)
Down-modulation of the genes encoding selected glucose
transporters employed short hairpin RNAs (shRNAs). All shRNAs
were purchased from the MISSION TRC library (Sigma) in the form
of bacterial glycerol stocks which were grown to obtain the purified
plasmids. Each gene was targeted by using three distinct shRNAs,
used individually (Table S1). For the lentiviral production, HEK
293FT cells (2.0 × 104 per well) were seeded in 96-well plates. On
the following day, cells were transfected with the packaging vectors
and each individual shRNA plasmid in a final concentration of
100 ng/well using the FuGENE 6 reagent (Promega), according to
the manufacturer’s instructions. The lentiviral particles were
collected in the supernatant of these cells approximately 60h af-
ter transfection and stored at 80 °C. For the transduction of
Huh7 cells and subsequent generation of cell lines with stable
knockdown of the genes of interest, cells (1.0 × 105 per well)
were seeded in 12-well plates. On the following day, the medium
was replaced by 400 μl of supplemented RPMI with 8 μg/ml of
polybrene, on top of which were added 100 μl of lentiviral
particles-containing supernantant [approximate multiplicity of
infection (MOI) of 1:1] and the plates were centrifuged for
30min at 1200 × g and 37 °C. Twenty-four hours after transduc-
tion, the medium was replaced by supplemented RPMI with
5 μg/ml of puromycin (Calbiochem) for the selection of the
transduced cells which were allowed to grow for at least a week
before being used for infections with luciferase-expressing or
GFP-expressing P. berghei sporozoites to determine overall
infection and parasite development by luminescence, flow cytom-
etry and microscopy, as described earlier. Cells transduced with
lentiviral particles carrying a negative control shRNA (SHC002)
not targeting any annotated gene in the human genome were
used as negative control. A stable cell line with the knockdown
of Scavenger receptor class B type I (SR-BI) was used as pos-
itive control in the luminescence assays (Rodrigues et al., 2008).
The knockdown efficiency of each shRNA sequence (Table S1)
was assessed by quantitative PCR (qPCR) with specific primers
for each gene (Table S2).
Small interfering RNA transfection
4.0 × 104 Huh7 cells were reverse-transfected with 30 nM of target
specific (human AMPK α1: ref. L-005027-00-0005; human AMPK
α2: ref. L-005361-00-0005) or control small interfering RNA
sequence pools (ON-TARGETplus SMARTpool, Dharmacon,
Lafayette, CO, USA), using Lipofectamine RNAiMAX (Gibco/
Invitrogen) according to the manufacturer’s instructions. Twenty-
four hours after transfection, the cells were infected with
3.0 × 104 GFP-expressing P. berghei sporozoites. Cells were col-
lected for flow cytometry analysis at 48 hpi and analysed on a
BD LSR Fortessa flow cytometer with the DIVA software (version
6.2). Analysis was carried out using the FLOWJO software (version
6.4.7, FlowJo). The efficiency of knockdown was assessed with
specific primers by qPCR (Table S2).
Fluorescence-activated cell sorting of P. berghei-infected
and non-infected Huh7 cells
Huh7 cells (1.0 × 105 per well) were seeded in 24-well plates and in-
fected 24 h later with 1.0 × 105 GFP-expressing P. berghei sporozo-
ites. Cells were collected at 2 hpi and FACS-sorted on a BD
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FACSAria III Cell Sorter (BD Biosciences). Non-infected and GFP-
expressing P. berghei-infected cells were gated on the basis of their
different fluorescence intensity, as previously established, and col-
lected simultaneously (Prudencio et al., 2008; Albuquerque et al.,
2009). Immediately after FACS-sorting, both infected and non-
infected cells were washed and seeded in 24-well plates at a density
of 1.5 × 105 per well. Infected cells were diluted 1:1 with non-infected
cells to allow replicates. Cells were then incubated until collection at
30 or 48 hpi. In the case of the 6 hpi time point, P. berghei-infected
cells were FACS-sorted at this time, diluted 1:1 with non-infected
cells, pelleted, snap-frozen and stored until RNA extraction.
RNA extraction, complementary DNA synthesis and qPCR
RNA was extracted from cultured cells using the High Pure RNA
Isolation kit (Roche, Basel, Switzerland) according to the manufac-
turer’s instructions. The amount of RNA in each sample was
assessed with a NanoDrop® ND-1000 spectrophotometer
(NanoDrop, Wilmington, DE, USA).
Complementary DNA (cDNA) was synthesised from 1 μg of RNA
using the Roche cDNA synthesis kit, according to the manufac-
turer’s instructions. The cDNA was synthesised employing the
following thermocycling parameters: 25 °C for 10min, 55 °C for
30min, and 85 °C for 5min. qPCR reaction was performed in a total
volume of 20 μl in a ABI Prism 7500 Fast system (Applied
Biosystems, Foster City, CA, USA) using the iTaqTM Universal
SYBR® Green kit (BioRad, Hercules, CA, USA) as follows: 50 °C
for 2min, 95 °C for 10min, 40 cycles at 95 °C for 15 s and 60 °C for
1min, melting stage was done at 95 °C for 15 s, 60 °C for 1min,
and 95 °C for 30 s. Primers for hypoxanthine-guanine
phosphoribosyltransferase (Hprt), a well-established housekeeping
gene, were used for normalisation in all experiments (TableS2). The
delta-delta cycle threshold (ΔΔCT) relative quantification method
was used for analysis of qPCR results.
In vivo WZB117 treatment, P. berghei sporozoite infection
and quantification of parasite liver load by qPCR
Six weeks old male C57BL/6 mice were injected intraperitoneally
(i.p.) with 10mg/kg of WZB117 in PBS/DMSO 1:1 (v/v), or with
vehicle alone, immediately before intravenous (i.v.) injection of
3.0 × 104 GFP-expressing P. berghei sporozoites (Liu et al., 2012).
The administration of the drug or vehicle was repeated at 15 and
30 hpi, and the livers were collected at 44 hpi and homogenised in
3ml of denaturing solution (4 M guanidine thiocyanate; 25mM
sodium citrate pH 7, 0.5% w/v N-lauroylsarcosine and v/v 0.7% β
mercaptoethanol in DEPC-treated water). Total RNA was extracted
from the livers with the NZY Total RNA Isolation Kit (NZYTech,
Lisboa, Portugal), according to the manufacturer’s protocol, and
converted into cDNA as described earlier. Parasite load was
quantified by qPCR using primers specific to P. berghei 18S RNA
(Table S2). Mouse Hprt expression was used for normalisation.
Immunohistochemical staining of liver sections
For microscopy, paraformaldehyde-fixed liver lobes were cut in
50 μm sections and were incubated in permeabilization/blocking
solution (1% w/v bovine serum albumin, 0.5% v/v Triton-X100 in
PBS) at room temperature for 1 h, followed by a 2 h incubation at
room temperature with an anti-UIS4 antibody (dilution 1:500). Slices
were further incubated in a 1:300 dilution of anti-GFP-Alexa488
antibody (Invitrogen) and anti-goat Alexa-Fluor 568 (Invitrogen) in
the presence of a 1:1000 dilution of Hoechst 33342 (Invitrogen)
and a 1:100 dilution of Phalloidin-660 (Invitrogen) for actin staining
for 1 h. After washing, slices were mounted on microscope slides
with Fluoromount (SouthernBiotech). Images were acquired and
processed as described above.
Determination of ATP levels inside single cells by live
microscopy
Huh7 cells (2.0 × 105 cells) were seeded on glass bottom microwell
dishes (MatTek). The following day, 1μg of ATeam plasmid carrying
the ATP indicator (pRSET-AT1.03) was transfected into the cells with
FuGENE 6 (Roche) according to the manufacturer’s instructions
(Imamura et al., 2009). Twenty-four hours after transfection, cells
were infectedwith RFP-expressingP. berghei sporozoites and, at se-
lected time points of infection, were visualised at 37 °C on a Zeiss
LSM 710 confocal microscope as described previously (Ando et al.,
2012). Huh7 cells incubated for 6 h in RPMI without glucose with
10mM of galactose and 10μM of Oligomycin were used as positive
controls for ATP depletion. Image analysis was performed using the
IMAGEJ software (version 1.47). The Venus/CFP emission ratio was
calculated for each cell dividing its mean intensity in the Venus chan-
nel by the mean intensity in the CFP channel.
Quantification of GLUT1 at the plasma membrane of
infected cells by flow cytometry
Huh7 cells (1.0 × 104 per well) were seeded in 96-well plates and
were infected with RFP-expressing P. berghei sporozoites on the
following day. Thirty and 48 hpi, cells were detached using PBS
containing 1mM EDTA, centrifuged at 4 °C, and the cell pellet was
resuspended in cold RPMI containing 10% v/v FBS. Cells were
further incubated with supernatant obtained from 293 T cells
transfected with a vector encoding the HRBD-EGFP fusion protein
(dilution 1:50 in PBS with 2% v/v FBS) (Manel et al., 2003; Kinet
et al., 2007). Following incubation at 37 °C for 30min, cells were
harvested by centrifugation, washed one time with PBS with 2%
v/v FBS, resuspended in the same buffer and analysed with a BD
LSR Fortessa cytometer with the DIVA software (version 6.2). Huh7
cells incubated overnight in complete RPMI with 250 μM of cobalt
(II) chloride (CoCl2) were used as positive controls (Koseoglu and
Beigi, 1999). Analysis was carried out using the FLOWJO software
(version 6.4.7, FlowJo).
Statistical analyses
Statistical analyses were performed using the GRAPHPAD PRISM 5
software (La Jolla, CA, USA). One-way analysis of variance, Two-
way analysis of variance, Chi-Square, Mann–Whitney U test or
Student’s t-test were used for significance of differences ob-
served, as indicated in each figure. ns, not significant; * P< 0.05,
** P< 0.01 and *** P< 0.001.
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Supporting information
Additional supporting information may be found in the online
version of this article at the publisher's web-site:
Fig. S1. Glucose availability impacts P. berghei infection
ex vivo. (A) Mouse primary hepatocytes were infected with
luciferase-expressing P. berghei sporozoites and the culture
medium was replaced 2 hpi by medium with different concen-
trations of glucose. Parasite load (luminescence) and cell via-
bility were assessed 48 hpi. Pool of 3 independent
experiments. Error bars represent SEM. One-way ANOVA with
post-test Dunnett. (B) Mouse primary hepatocytes were in-
fected with GFP-expressing P. berghei sporozoites and the
culture medium was replaced by medium with different con-
centrations of glucose 2 hpi. Parasite development and the to-
tal number of infected cells were assessed at 48 hpi by flow
cytometry by determining the fluorescence intensity and the
number of GFP+ cells, respectively. One experiment. One-
way ANOVA with post-test Dunnett. Error bars represent SD.
ns - not significant, * P< 0.05, ** P< 0.01 and *** P< 0.001.
Fig. S2. Gating strategy to determine 2-NBDG uptake and par-
asite development by flow cytometry. Huh7 cells were infected
with RFP-expressing P. berghei sporozoites and incubated
with 2-NBDG-containing medium at different time points of
infection. Dot plot represents non-infected and infected
(RFP+) cells of one replicate from the 48 h time point. Left
histogram shows the different fluorescence intensity displayed
by non-developing (RFPlow) and developing (RFPhigh) para-
sites. Right histogram exemplifies the 2-NBDG uptake by the
different cell populations (non-infected, non-developing and
developing parasites), assessed as an increased fluorescence
intensity in the green channel.
Fig. S3. P. berghei-infected Huh7 cells and developing para-
sites uptake more 2-NBDG than non-infected and naïve cells.
Huh7 cells were infected with RFP-expressing P. berghei
sporozoites and incubated for 30min with 2-NBDG-containing
medium at 48 hpi. (A) Representative images of P. berghei-
infected Huh7 cells with or without incubation with 2-NBDG. A
non-infected cell, an infected cell and a parasite are outlined
in yellow, pink and red, respectively. Scale bar, 20 μm. (B)
Quantification of 2-NBDG uptake by naïve (grey bar), non-
infected cells (yellow bar), infected cells (pink bar) and develop-
ing parasites (red bar), as assessed by live fluorescence
microscopy. Representative experiment out of 2 independent
experiments. One-way ANOVA with post-test Bonferroni and
two-tailed Mann-Whitney test, respectively. Error bars repre-
sent SD. *** P< 0.001.
Fig. S4. Quantification of the percentage of MHV-68-YFP-
infected cells by flow cytometry. Percentage of YFP+ cells 24
hpi with different loads of MHV-68-YFP.
Fig. S5. 2-NBDG uptake by non-infected Huh7 cells with
GLUT1 knockdown. 2-NBDG uptake by non-infected cells of
the different cell lines with GLUT1 knockdown at 48 hpi,
assessed by flow cytometry. Pool of 4 independent experi-
ments. Error bars represent SEM. One-way ANOVA with
post-test Dunnett. ns - not significant and *** P< 0.001.
Fig. S6. Chemical inhibition of GLUT1-mediated glucose trans-
port by WZB117 affects P. berghei hepatic infection ex vivo. (A)
Mouse primary hepatocytes were infected with luciferase-
expressing P. berghei sporozoites and 2 h later the culture
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medium was replaced by medium containing WZB117.
Parasite load (luminescence) and cell viability were assessed
at 48 hpi. Pool of 2 independent experiments. Error bars repre-
sent SEM. One-way ANOVA with post-test Dunnett. (B) Mouse
primary hepatocytes were infected with GFP-expressing
P. berghei sporozoites and 2h later the culture medium was re-
placed by medium containing WZB117. Parasite development
was assessed by flow cytometry at 48 hpi. Error bars represent
SD. One-way ANOVA with post-test Dunnett. ns - not signifi-
cant, * P< 0.05, ** P< 0.01 and *** P< 0.001.
Fig. S7. GLUT1 expression is not altered in P. berghei-infected
cells. qPCR quantification of GLUT1 transcriptional expression
in FACS-sorted infected and non-infected Huh7 cells. Each
time point represents a pool of 2 independent sorting experi-
ments. Error bars represent SD. Two-tailed Mann-Whitney test.
ns – not significant.
Fig. S8. Increased GLUT1-dependent glucose uptake into
P. berghei-infected cells is independent of AMPK. (A) Knock-
down efficiency upon transfection in Huh7 cells of the siRNAs
used against the α1 and α2 subunits of AMPK. (B) Huh7 cells
with the knockdown of α1 or/and α2 subunits of AMPK were in-
fectedwithGFP-expressingP. berghei sporozoites and parasite
development was assessed by flow cytometry at 48 hpi. Pool of
2 independent experiments. Error bars represent SD. One-way
ANOVAwith post-test Dunnett. (C) 2-NBDG uptake at 48 hpi by
developing parasites-containing cells with the knockdown of α1
or/and α2 subunits of AMPK, assessed by flow cytometry.
Representative experiment out of 2 independent experiments.
Error bars represent SD. One-way ANOVA with post-test
Dunnett. ns - not significant, *** p< 0.001.
Fig. S9.PI3K stimulation or inhibition does not impactP. berghei
infection of Huh7 cells neither does it alter glucose uptake by in-
fected cells. Huh7 cells were infected with luciferase-expressing
P. berghei sporozoites and 2h later were treated with different
concentrations of (A) insulin or (B) Wortmannin. Parasite load
(luminescence) was assessed after 48h. Representative experi-
ment out of 2 andpool of 3 independent experiments, respectively.
Error bars represent SD. To evaluate possible effects on glucose
uptake, Huh7 cells were infected with RFP-expressing P. berghei
sporozoites and the treatment with different concentrations of
insulin (C) and Wortmannin (D) was initiated 2 hpi. 2-NBDG
uptake by developing parasites-containing cells was assessed at
48 hpi by flow cytometry. Pool of 2 independent experiments for
both insulin andWortmannin. Error bars represent SD. All panels:
one-way ANOVA with post-test Dunnett. ns - not significant.
Table S1. List of shRNA sequences used, with the corresponding
knockdowns.
Table S2. List of primer sequences.
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